Today: 12 April 2026
Subscribe
Browse Category

Stock Market 3 December 2025 - 4 December 2025

Dollar Tree (DLTR) Stock Jumps on Q3 2025 Earnings Beat and Guidance Hike – Is There More Upside Ahead?

Dollar Tree (DLTR) Stock Jumps on Q3 2025 Earnings Beat and Guidance Hike – Is There More Upside Ahead?

Dollar Tree reported Q3 net sales of $4.7 billion, up 9.4% year over year, and raised its full-year profit outlook. Shares closed at $112.92 on December 3, up 3.6% and near the top of their 52-week range. The stock has gained about 45–50% in 2025. Analyst targets vary widely, with most ratings at “Hold” and price targets from $70 to $135.
4 December 2025
··
Accenture (ACN) Stock Jumps on AI Deals and Fresh Institutional Buying: Latest News, Price Action and 2026 Forecasts

Accenture (ACN) Stock Jumps on AI Deals and Fresh Institutional Buying: Latest News, Price Action and 2026 Forecasts

Accenture shares closed at $272.85 on Dec. 3, up 4.5% but still 30% below their 52-week high. Fiscal 2025 revenue beat forecasts at $17.6 billion, with record AI-related bookings, though 2026 guidance projects only 2–5% growth. New AI partnerships with OpenAI and Snowflake are expanding. Institutions continue to buy, while insiders sold over 33,000 shares in recent months.
4 December 2025
··
Johnson & Johnson (JNJ) Stock on December 3, 2025: Analyst Upgrades, Options Signals and New Drug Wins at Near‑Record Highs

Johnson & Johnson (JNJ) Stock on December 3, 2025: Analyst Upgrades, Options Signals and New Drug Wins at Near‑Record Highs

Johnson & Johnson traded near $206 on Wednesday, close to its 52-week high after a 40% rally this year. Guggenheim reiterated a Buy rating and $206 target, citing strong multiple myeloma trial results. Barclays raised its target to $197 but kept an Equal Weight rating. The company launched a vision-care campaign with Naomi Watts and received European approval for its autoimmune drug IMAAVY.
4 December 2025
··
Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific Stock (BSX) on December 3, 2025: Insider Sales, EU Device Win and Strong 2026 Price Targets

Boston Scientific (BSX) closed at $98.57 on December 3, down slightly, with shares trading in a $97.60–$99.30 range. EVP Arthur Butcher sold 17,313 shares on December 1 for about $1.76 million under a pre-arranged plan. The stock is up roughly 8–9% over the past year but remains about 9.6% below its September high. The company also received new European device approvals this week.
4 December 2025
·
Adobe Stock Today: ADBE Near 52‑Week Lows Ahead of Q4 2025 Earnings — Is the Market Mispricing Its AI Pivot?

Adobe Stock Today: ADBE Near 52‑Week Lows Ahead of Q4 2025 Earnings — Is the Market Mispricing Its AI Pivot?

Adobe shares closed at $326.78 on December 3, 2025, near the bottom of their 52-week range and about 40% below last year’s high. Investors await Q4 earnings on December 10 as retail traders bet on a rebound, with prediction markets giving a 91% chance of an earnings beat. Invesco raised its stake by 16.1% in Q2, now holding over 4.4 million shares.
4 December 2025
···
Chevron (CVX) Stock on December 3, 2025: New $19 Billion Capex Plan, Syria Talks and HSBC Upgrade Reset the Outlook

Chevron (CVX) Stock on December 3, 2025: New $19 Billion Capex Plan, Syria Talks and HSBC Upgrade Reset the Outlook

Chevron shares closed at $151.60 on December 3, up nearly 1%, valuing the company above $300 billion. The firm announced a 2026 capital spending plan of $18–19 billion, emphasizing U.S. shale and offshore projects. HSBC upgraded Chevron to “strong-buy” with a $169 target. The stock’s five-year total return with dividends now outpaces the S&P 500.
4 December 2025
··
Qualcomm (QCOM) Stock on December 3, 2025: AI Momentum, Hedge Fund Buying, Options Surge and Dividend Deadline

Qualcomm (QCOM) Stock on December 3, 2025: AI Momentum, Hedge Fund Buying, Options Surge and Dividend Deadline

Qualcomm shares closed at $175.07 on December 3, up 2.6%, after a surge in call option activity and strong Q4 results. Revenue for the quarter reached $11.3 billion, beating estimates, with chip business sales up 13% year-over-year. The stock remains about 15% below its 52-week high. Traders bought over 105,000 call contracts, 73% above average daily volume.
4 December 2025
··
NXP Semiconductors (NXPI) Stock Jumps Again on December 3, 2025: Dividend Rush, AI Tailwinds and Auto Rebound Fuel Rally

NXP Semiconductors (NXPI) Stock Jumps Again on December 3, 2025: Dividend Rush, AI Tailwinds and Auto Rebound Fuel Rally

NXP Semiconductors closed at $227.56 on December 3, up 5.7% for the day and about 14% over two sessions, with trading volume around 4.6 million shares. The stock’s rally follows stronger-than-expected Q3 revenue of $3.17–3.20 billion and improved Q4 guidance, as buyers position ahead of the company’s ex-dividend date.
4 December 2025
···
Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health shares fell 2.64% to $199.71 on December 3, 2025, marking a fifth straight daily loss and leaving the stock 7% below its November 52-week high. The drop came despite gains in major indices. Recent filings show OMERS and Quantbot Technologies increased their stakes in the company. Cardinal Health has returned 74% over the past year.
4 December 2025
·
McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson Corporation (MCK) Stock Today: Price Drop, Oncology Push and 2026 Outlook as of December 3, 2025

McKesson shares closed at $805.37 on December 3, down 2.93% and about 10% below their 52-week high near $895. The drop follows profit-taking, portfolio moves, and investor reaction to new guidance and a planned Med-Surg spin-off. Despite the decline, the stock remains up over 30% for the year. Analysts maintain bullish ratings, with price targets above current levels.
4 December 2025
·
Home Depot (HD) Stock Today: Q3 2025 Earnings Miss, Dividend Deadline and December 2025 Outlook

Home Depot (HD) Stock Today: Q3 2025 Earnings Miss, Dividend Deadline and December 2025 Outlook

Home Depot shares closed at $357.91 on December 3, up 1.1% but 18% below last year’s high. The company beat Q3 sales estimates but missed on profit and cut its full-year outlook. Heavy call option activity followed, along with shareholder fraud probes by law firms. Home Depot also announced a $2.30 dividend and expanded its Instacart partnership in Canada.
3 December 2025
···
Fiserv (FISV) Stock Jumps on Insider Buying as New Lawsuit and Black Friday Data Define a High-Risk 2025 Turnaround – December 3, 2025 Update

Fiserv (FISV) Stock Jumps on Insider Buying as New Lawsuit and Black Friday Data Define a High-Risk 2025 Turnaround – December 3, 2025 Update

Fiserv shares jumped nearly 6% to $66.95 on December 3, 2025, after insider buying disclosures, despite news of a new securities class-action lawsuit. Trading volume surged to 14.9 million shares. The stock remains down about 70% from its 52-week high after a steep selloff in October. New CFO Paul Todd bought $1.06 million in shares, while two other executives also made large purchases.
3 December 2025
·
Seagate (STX) Stock on December 3, 2025: Insider Selling, AI Tailwinds and Fresh Wall Street Price Targets

Seagate (STX) Stock on December 3, 2025: Insider Selling, AI Tailwinds and Fresh Wall Street Price Targets

Seagate shares closed at $258.67 on December 3, down 3% and marking a third straight decline despite gains in the broader market. CEO William Mosley sold about 20,000 shares earlier this week for $5.4 million, while options activity showed increased bearish bets. The stock remains up over 180% for the year, about 13% below its November 52-week high.
3 December 2025
·
UiPath (PATH) Surges After Q3 Fiscal 2026 Earnings and Guidance Top Wall Street Expectations

UiPath (PATH) Surges After Q3 Fiscal 2026 Earnings and Guidance Top Wall Street Expectations

UiPath reported fiscal Q3 2026 revenue of $411 million, up 16% year over year, and posted its first GAAP-profitable third quarter. GAAP net income reached $198.8 million, or $0.37 per share, aided by a large tax benefit. Non-GAAP EPS was $0.16, beating analyst estimates. The company forecast Q4 revenue of $462–$467 million, above consensus.
3 December 2025
···
Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Mastercard Stock (MA) Today: AI Payments, Analyst Price Targets and 2026 Outlook – December 3, 2025

Mastercard closed at $553.73 on December 3, 2025, near the middle of its 52-week range. The company unveiled Mastercard Credit Intelligence, an AI-powered lending analytics suite now live in several markets, and announced Agent Pay, an AI agent payment platform set to launch in Latin America and the Caribbean from 2026. Market cap stands just under $490 billion. Institutional ownership is around 97%.
3 December 2025
··
Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

Goldman Sachs (GS) Stock on December 3, 2025: Near Record Highs After Dividend Hike, $2 Billion ETF Deal and Mixed 2026 Forecasts

Goldman Sachs closed at about $836.60 on December 3, 2025, near its 52-week high, with a market cap around $260 billion and a dividend yield just under 2%. The bank confirmed a $4.00 quarterly dividend with an ex-dividend date of December 2. Goldman also announced a $2 billion deal to acquire Innovator Capital Management, expanding its ETF platform.
3 December 2025
···
Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally

Amgen shares closed at $345.42 on December 3, 2025, up 2% and setting a new 52-week high near $345.95. The stock has gained about 35% year-to-date and over 25% in the past year. Amgen beat Q3 earnings forecasts and raised full-year guidance, but analysts’ 12-month targets mostly remain below current prices. The consensus rating ranges from “Hold” to “Moderate Buy.”
3 December 2025
··
Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

Freeport-McMoRan (FCX) Stock Soars as Copper Rallies but Lawsuits Mount: Latest News and 2026–2027 Outlook (December 3, 2025)

Freeport-McMoRan (FCX) closed at $44.53 on December 3, up 3.63% with volume topping 22.8 million shares, but remains 9.3% below its July high after a September mud-rush accident at its Grasberg mine. The incident killed two, left five missing, and forced a force majeure on copper supplies, with analysts projecting a 35% production cut in 2026 and full recovery unlikely before 2027.
3 December 2025
··
D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

D-Wave Quantum (QBTS) Stock on December 3, 2025: New U.S. Government Unit, Evercore’s $44 Target and What It Means for Investors

D-Wave Quantum shares jumped 11% to $25.08 after launching a U.S. Government Business Unit focused on federal contracts. Evercore ISI began coverage with an “Outperform” rating and a $44 target. The stock’s market cap stands near $8 billion, up 168% year to date, with short interest over 19%. Volatility remains high, with swings of 10–30% per session.
3 December 2025
··
1 … 1,087 1,088 1,089 1,090 1,091 … 1,375

Stock Market Today

  • Campbell's (CSC) Price Target Cut 17.85% to €23 Amid Fund Ownership Shifts
    April 12, 2026, 5:11 AM EDT. Campbell's (XTRA:CSC) average one-year price target dropped 17.85% to €23 from €28 on Feb 23, 2026, despite still implying a 28.51% rise from its €17.90 closing price. Analyst targets vary widely between €17.40 and €53.57. Institutional ownership declined by 18.11% to 180.1 million shares, with 626 funds reporting positions down by 47.22% last quarter. Fund portfolio weighting in Campbell's rose 20.03% to 0.15%. Notable investors include Invesco, which raised holdings by 17.73%, and Beutel Goodman & Co, which trimmed shares by 7.56%. These shifts highlight mixed fund sentiment amid analysts' more cautious outlook on Campbell's stock.

Latest article

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Go toTop